Medicines Horizon Scanning Annual Report 2024

This annual report summarises the horizon scanning strategy used to identify newly created or updated records within 2024. It also gives an overview of the landscape of clinical trials in remit, the therapeutic areas of the indications based on NICE condition categories, drug designations, industry developers and gives some high-level conclusions based on the themes and patterns identified.